The global infertility drugs Market Growth Accelerated by Rising Prevalence of Infertility

Infertility drugs are used to treat fertility issues and assist in conception. They include fertility medications such as clomiphene citrate, letrozole, gonadotropins and aromatase inhibitors which help stimulate and regulate the release of eggs and improve the chances of fertilization and embryo implantation. The global infertility drugs market is witnessing significant growth due to the rising prevalence of infertility worldwide attributed to increasing stress levels, lifestyle changes, obesity, genetics and reproductive health issues.

The global infertility drugs Market is estimated to be valued at US$ 4262.17 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The key trend driving the growth of the Global Infertility Drugs Market Size is the increasing prevalence of risk factors associated with infertility. Sedentary lifestyles, obesity, and stress are major factors contributing to infertility issues. According to the National Center for Biotechnology Information, between 12-18% of couples face primary or secondary infertility globally. Additionally, factors such as consumption of alcohol, tobacco and drugs, radiation exposure, chemotherapy, and diabetes increase the risk of infertility. Technological advancements have enabled the development of innovative assisted reproductive techniques like in-vitro fertilization and intracytoplasmic sperm injection which are boosting the usage of infertility drugs and treatment procedures.

Segment Analysis

 Among the product segments, the gonadotropins dominate the overall market. Gonadotropins stimulate follicle maturation and development. They play a vital role in inducing ovulation and pregnancy. Clomid is another commonly used drug for ovulation induction in polycystic ovary syndrome (PCOS). Clomid blocks receptors of estrogen to stimulate the hypothalamus and pituitary to produce more gonadotropins - FSH and LH.

Key Takeaways
The global infertility drugs market is expected to witness high growth over the forecast period. The global infertility drugs Market is estimated to be valued at US$ 4262.17 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2031.

Regional analysis:

The Asia Pacific region is expected to register the highest CAGR during the forecast period. This is attributed to the presence of emerging economies like India and China. India has become a preferred destination for medical tourism in recent years. Furthermore, increasing healthcare expenditure, rising adoption of advanced infertility treatment procedures and early adoption of new infertility drugs are contributing to the market growth in Asia Pacific.

Key players:
Key players operating in the Infertility Drugs market are Koninklijke Philips N.V., LifeWatch USA, Tunstall, Apple Inc., ADT Security Services, Medical Guardian LLC, MobileHelp, Bay Alarm Company, MariCare Oy, Origin Wireless, The ADT Corporation, Singapore Technologies Electronics Limited, Semtech Corporation.

Get More Insights On This Topic: https://www.ukwebwire.com/infertility-drugs-market-size-share-analysis-2023-2030/

Explore More Trending Article On This Topic: https://masstamilan.tv/printed-electronics-the-future-of-electronics-manufacturing/